Pulmonology

 
ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics
May 12, 2021

ATS.2021. Study authors categorized asthma patients using age at onset, T2 biomarkers, and IL-6 levels, creating 12 phenotypes for additional study.

ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk
May 12, 2021

ATS 2021: The risk of morbidity and death in patients with COPD increases among those with moderate exacerbation, and even more so for severe exacerbation, new research suggests.

ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US
May 11, 2021

In an abstract being presenting at the upcoming ATS 2021 International Conference, researchers estimate that by 2050 the US will lead the Americas in prevalence of COPD.

ATS 2021: Triple Combination Therapy May Benefit “Wide Spectrum” of Patients with COPD
May 11, 2021

American Thoracic Society 2021 International Conference: In a subset of patients from the ETHOS study, triple combination therapy was found beneficial for those with moderate COPD.

Study: GLP-1 Receptor Agonist Therapy Reduces Asthma Exacerbations in Adults with Asthma, T2D
April 26, 2021

New findings suggest that patients with asthma and type 2 diabetes who use GLP-1 RAs for diabetes treatment intensification have fewer asthma exacerbations compared to other diabetes drugs.

Extended Exposure to Air Pollution Raises Hospitalization Risk in COVID-19 Patients with Pre-existing Respiratory Diseases
April 20, 2021

Patients with asthma or COPD living in areas with high levels of air pollution are at an increased risk of hospitalization if they contract COVID-19, suggests a new pilot study.

Long COVID Review Lead Author Highlights Knowns, Unknowns
April 09, 2021

Long COVID is now a term recognized worldwide. We talked with Ani Nalbandian, MD, lead author of the most comprehensive review-to-date, about what she and her colleagues have learned.

Asthma of Obesity: Investigator Explains the Phenotypes
March 25, 2021

Asthma of obesity affects more than 10% of men and 14% of women with obesity. Our interview with researcher Anne Dixon, MD, sheds light on this poorly appreciated asthma phenotype.

Biologic Therapy for Asthma & COPD: 8 Questions on Targets, Pathways, & mAbs
March 24, 2021

Research into biologic therapy for asthma and COPD has been both successful and frustrating. Find out what you know about the progress with these 8 questions.

Asthma Guidelines in Practice: Clinicians Rate their Adherence
March 18, 2021

How do clinicians who treat asthma rate their own adherence to tenets of evidence-based guidelines? Lead authors on analyses of a national survey respond.